Efficacy of stem cell in improvement of left ventricular function in acute myocardial infarction - MI3 Trial

BACKGROUND & OBJECTIVES: Acute myocardial infarction (AMI) is characterized by irreparable and irreversible loss of cardiac myocytes. Despite major advances in the management of AMI, a large number of patients are left with reduced left ventricular ejection fraction (LVEF), which is a major dete...

Descripción completa

Detalles Bibliográficos
Autores principales: Nair, Velu, Madan, Hemant, Sofat, Sunil, Ganguli, Prosenjit, Jacob, M.J., Datta, Rajat, Bharadwaj, Prashant, Sarkar, R.S., Pandit, A.J., Nityanand, Soniya, Goel, Pravin K., Garg, Naveen, Gambhir, Sanjay, George, Paul V., Chandy, Sunil, Mathews, Vikram, George, Oomen K., Talwar, K.K., Bahl, Ajay, Marwah, Neelam, Bhatacharya, Anish, Bhargava, Balram, Airan, Balram, Mohanty, Sujata, Patel, Chetan D., Sharma, Alka, Bhatnagar, Shinjini, Mondal, A., Jose, Jacob, Srivastava, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4613437/
https://www.ncbi.nlm.nih.gov/pubmed/26354213
http://dx.doi.org/10.4103/0971-5916.164245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4613437/
https://www.ncbi.nlm.nih.gov/pubmed/26354213
http://dx.doi.org/10.4103/0971-5916.164245

Ejemplares similares